Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline character... von James, Stefan, MD, Åkerblom, Axel, MD, Cannon, Christopher P., MD, Emanuelsson, Håkan, MD, Husted, Steen, MD, Katus, Hugo, MD, PhD, Skene, Allan, PhD, Steg, Philippe Gabriel, MD, Storey, Robert F., MD, Harrington, Robert, MD, Becker, Richard, MD, Wallentin, Lars, MD

Volltext

Next-Generation Sequencing of CYP2C19 in Stent Thrombosis: Implications for Clopidogrel Pharmacogenomics von Morales-Rosado, Joel A., Goel, Kashish, Zhang, Lingxin, Åkerblom, Axel, Baheti, Saurabh, Black, John L., Eriksson, Niclas, Wallentin, Lars, James, Stefan, Storey, Robert F., Goodman, Shaun G., Jenkins, Gregory D., Eckloff, Bruce W., Bielinski, Suzette J., Sicotte, Hugues, Johnson, Stephen, Roger, Veronique L., Wang, Liewei, Weinshilboum, Richard, Klee, Eric W., Rihal, Charanjit S., Pereira, Naveen L.

Volltext

Effects of DAPAgliflozin on CARDiac substrate uptake, myocardial efficiency, and myocardial contractile work in type 2 diabetes patients-a description of the DAPACARD study von Åkerblom, Axel, Oldgren, Jonas, Latva-Rasku, Aino, Johansson, Lars, Lisovskaja, Vera, Karlsson, Cecilia, Oscarsson, Jan, Nuutila, Pirjo

Volltext

Eptifibatide is noninferior to abciximab in primary percutaneous coronary intervention: results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) von Akerblom, Axel, James, Stefan K, Koutouzis, Michail, Lagerqvist, Bo, Stenestrand, Ulf, Svennblad, Bodil, Oldgren, Jonas

Volltext

Seasonal variations of urate in a Swedish adult population von Åkerblom, Axel, Helmersson-Karlqvist, Johanna, Weitoft, Tomas, Larsson, Anders

Volltext

SGLT2 inhibition reduces myocardial oxygen consumption von Søndergaard, Esben, Lauritzen, Esben S., Lauritsen, Katrine M., Åkerblom, Axel, Nuutila, Pirjo, Oldgren, Jonas, Gormsen, Lars C.

Volltext

Effect of genetic variations on ticagrelor plasma levels and clinical outcomes von Varenhorst, Christoph, Eriksson, Niclas, Johansson, Åsa, Barratt, Bryan J, Hagström, Emil, Åkerblom, Axel, Syvänen, Ann-Christine, Becker, Richard C, James, Stefan K, Katus, Hugo A, Husted, Steen, Steg, Ph Gabriel, Siegbahn, Agneta, Voora, Deepak, Teng, Renli, Storey, Robert F, Wallentin, Lars

Volltext

Effects of 6 weeks of treatment with dapagliflozin, a sodium‐glucose co‐transporter‐2 inhibitor, on myocardial function and metabolism in patients with type 2 diabetes: A randomize... von Oldgren, Jonas, Laurila, Sanna, Åkerblom, Axel, Latva‐Rasku, Aino, Rebelos, Eleni, Isackson, Henrik, Saarenhovi, Maria, Eriksson, Olof, Heurling, Kerstin, Johansson, Edvin, Wilderäng, Ulrica, Karlsson, Cecilia, Esterline, Russell, Ferrannini, Ele, Oscarsson, Jan, Nuutila, Pirjo

Volltext

Safety and efficacy of the 5-lipoxygenase-activating protein inhibitor AZD5718 in patients with recent myocardial infarction: The phase 2a FLAVOUR study von Prescott, Eva, Angerås, Oskar, Erlinge, David, Grove, Erik L., Hedman, Marja, Jensen, Lisette O., Pernow, John, Saraste, Antti, Åkerblom, Axel, Svedlund, Sara, Rudvik, Anna, Knöchel, Jane, Lindstedt, Eva-Lotte, Garkaviy, Pavlo, Gan, Li-Ming, Gabrielsen, Anders

Volltext

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction Patients With Renal Dysfunction von Evans, Marie, MD, PhD, Carrero, Juan-Jesus, PhD, Szummer, Karolina, MD, PhD, Åkerblom, Axel, MD, PhD, Edfors, Robert, MD, Spaak, Jonas, MD, PhD, Jacobson, Stefan H., MD, PhD, Andell, Pontus, MD, Lindhagen, Lars, PhD, Jernberg, Tomas, MD, PhD

Volltext

Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline charact... von James, Stefan, Akerblom, Axel, Cannon, Christopher P, Emanuelsson, Håkan, Husted, Steen, Katus, Hugo, Skene, Allan, Steg, Philippe Gabriel, Storey, Robert F, Harrington, Robert, Becker, Richard, Wallentin, Lars

Volltext

Population Trends in Percutaneous Coronary Intervention: 20-Year Results From the SCAAR (Swedish Coronary Angiography and Angioplasty Registry) von FOKKEMA, Marieke L, JAMES, Stefan K, THORVINGER, Björn, LAGERQVIST, Bo, ALBERTSSON, Per, AKERBLOM, Axel, CALAIS, Fredrik, ERIKSSON, Peter, JENSEN, Jens, NILSSON, Tage, DE SMET, Bart J, SJÖGREN, Iwar

Volltext

C-X-C Ligand 16 Is an Independent Predictor of Cardiovascular Death and Morbidity in Acute Coronary Syndromes von Andersen, Thomas, Ueland, Thor, Ghukasyan Lakic, Tatevik, Åkerblom, Axel, Bertilsson, Maria, Aukrust, Pål, Michelsen, Annika E, James, Stefan K, Becker, Richard C, Storey, Robert F, Wallentin, Lars, Siegbahn, Agneta, Kontny, Frederic

Volltext

Admission Levels of DKK1 (Dickkopf-1) Are Associated With Future Cardiovascular Death in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial von Ueland, Thor, Åkerblom, Axel, Ghukasyan, Tatevik, Michelsen, Annika E, Becker, Richard C, Bertilsson, Maria, Himmelmann, Anders, James, Stefan K, Siegbahn, Agneta, Storey, Robert F, Kontny, Frederic, Aukrust, Pål, Wallentin, Lars

Volltext

Treatments and Mortality Trends in Cases With and Without Dialysis Who Have an Acute Myocardial Infarction: An 18-Year Nationwide Experience von Szummer, Karolina, Lindhagen, Lars, Evans, Marie, Spaak, Jonas, Koul, Sasha, Åkerblom, Axel, Carrero, Juan Jesus, Jernberg, Tomas

Volltext

Association of the coronary artery disease risk gene GUCY1A3 with ischaemic events after coronary intervention von Kessler, Thorsten, Wolf, Bernhard, Eriksson, Niclas, Kofink, Daniel, Mahmoodi, Bakhtawar K, Rai, Himanshu, Tragante, Vinicius, Åkerblom, Axel, Becker, Richard C, Bernlochner, Isabell, Bopp, Roman, James, Stefan, Katus, Hugo A, Mayer, Katharina, Munz, Matthias, Nordio, Francesco, O’Donoghue, Michelle L, Sager, Hendrik B, Sibbing, Dirk, Solakov, Linda, Storey, Robert F, Wobst, Jana, Asselbergs, Folkert W, Byrne, Robert A, Erdmann, Jeanette, Koenig, Wolfgang, Laugwitz, Karl-Ludwig, ten Berg, Jurrien M, Wallentin, Lars, Kastrati, Adnan, Schunkert, Heribert

Volltext

Ticagrelor in patients with heart failure after acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial von Åkerblom, Axel, Wojdyla, Daniel M., Wallentin, Lars, James, Stefan K., de Souza Brito, Flávio, Steg, Philippe Gabriel, Cannon, Christopher P., Katus, Hugo A., Himmelmann, Anders, Storey, Robert F., Becker, Richard C., Lopes, Renato D.

Volltext

Legumain in Acute Coronary Syndromes: A Substudy of the PLATO (Platelet Inhibition and Patient Outcomes) Trial von Gregersen, Ida, Michelsen, Annika E., Ngoc Nguyen Lunde, Akerblom, Axel, Lakic, Tatevik G., Skjelland, Mona, Skagen, Karolina Ryeng, Becker, Richard C., Lindback, Johan, Himmelmann, Anders, Solberg, Rigmor, Johansen, Harald T., James, Stefan K., Siegbahn, Agneta, Storey, Robert F., Kontny, Frederic, Aukrust, Pal, Ueland, Thor, Wallentin, Lars, Halvorsen, Bente

Volltext

Eptifibatide Is Noninferior to Abciximab in Primary Percutaneous Coronary Intervention von Åkerblom, Axel, MD, James, Stefan K., MD, PhD, Koutouzis, Michail, MD, PhD, Lagerqvist, Bo, MD, PhD, Stenestrand, Ulf, MD, PhD, Svennblad, Bodil, PhD, Oldgren, Jonas, MD, PhD

Volltext

ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial von Ueland, Thor, Åkerblom, Axel, Ghukasyan, Tatevik, Michelsen, Annika E., Becker, Richard C., Bertilsson, Maria, Budaj, Andrzej, Cornel, Jan H., Himmelmann, Anders, James, Stefan K., Siegbahn, Agneta, Storey, Robert F., Kontny, Frederic, Aukrust, Pål, Wallentin, Lars

Volltext